175 related articles for article (PubMed ID: 31713940)
21. Association of Suicidality and Depression With 5α-Reductase Inhibitors.
Welk B; McArthur E; Ordon M; Anderson KK; Hayward J; Dixon S
JAMA Intern Med; 2017 May; 177(5):683-691. PubMed ID: 28319231
[TBL] [Abstract][Full Text] [Related]
22. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
[TBL] [Abstract][Full Text] [Related]
23. Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal).
Collins GS; Altman DG
Eur J Cancer; 2013 Mar; 49(5):1040-8. PubMed ID: 23159533
[TBL] [Abstract][Full Text] [Related]
24. Identifying patients with suspected gastro-oesophageal cancer in primary care: derivation and validation of an algorithm.
Hippisley-Cox J; Coupland C
Br J Gen Pract; 2011 Nov; 61(592):e707-14. PubMed ID: 22054334
[TBL] [Abstract][Full Text] [Related]
25. Recurrent antibiotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota?
Boursi B; Mamtani R; Haynes K; Yang YX
Eur J Cancer; 2015 Nov; 51(17):2655-64. PubMed ID: 26338196
[TBL] [Abstract][Full Text] [Related]
26. Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2013 Jan; 346():f114. PubMed ID: 23325866
[TBL] [Abstract][Full Text] [Related]
27. Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma.
Ye W; Chow WH; Lagergren J; Boffetta P; Boman G; Adami HO; Nyrén O
Br J Cancer; 2001 Nov; 85(9):1317-21. PubMed ID: 11720467
[TBL] [Abstract][Full Text] [Related]
28. A population-based nested case-control study: the use of 5-alpha-reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia.
Lin WL; Hsieh YW; Lin CL; Sung FC; Wu CH; Kao CH
Clin Endocrinol (Oxf); 2015 Apr; 82(4):503-8. PubMed ID: 25158777
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas.
Lindblad M; García Rodríguez LA; Chandanos E; Lagergren J
Br J Cancer; 2006 Jan; 94(1):136-41. PubMed ID: 16404367
[TBL] [Abstract][Full Text] [Related]
30. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
31. Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia.
Freedman J; Lagergren J; Bergström R; Näslund E; Nyrén O
Br J Surg; 2000 Aug; 87(8):1087-93. PubMed ID: 10931056
[TBL] [Abstract][Full Text] [Related]
32. Exposure to Ranitidine and Risk of Bladder Cancer: A Nested Case-Control Study.
Cardwell CR; McDowell RD; Hughes CM; Hicks B; Murchie P
Am J Gastroenterol; 2021 Aug; 116(8):1612-1619. PubMed ID: 34028367
[TBL] [Abstract][Full Text] [Related]
33. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
Tan MC; El-Serag HB; Yu X; Thrift AP
Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
[TBL] [Abstract][Full Text] [Related]
34. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.
Green J; Czanner G; Reeves G; Watson J; Wise L; Beral V
BMJ; 2010 Sep; 341():c4444. PubMed ID: 20813820
[TBL] [Abstract][Full Text] [Related]
35. A population-based nested case-control study in taiwan: use of 5α-reductase inhibitors did not decrease prostate cancer risk in patients with benign prostate hyperplasia.
Liang JA; Sun LM; Lin MC; Chang SN; Sung FC; Muo CH; Kao CH
Oncologist; 2012; 17(7):986-91. PubMed ID: 22723508
[TBL] [Abstract][Full Text] [Related]
36. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
Pandeya N; Webb PM; Sadeghi S; Green AC; Whiteman DC;
Gut; 2010 Jan; 59(1):31-8. PubMed ID: 19875392
[TBL] [Abstract][Full Text] [Related]
37. Exploration of Novel 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia by 2D/3D QSAR, Cytotoxicity Pre-ADME and Docking Studies.
Dhingra R; Malhotra M; Sharma V; Bhardwaj TR; Dhingra N
Curr Top Med Chem; 2018; 18(32):2816-2834. PubMed ID: 30659542
[TBL] [Abstract][Full Text] [Related]
38. Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia.
Rubenstein JH; Davis J; Marrero JA; Inadomi JM
Aliment Pharmacol Ther; 2005 Aug; 22(3):267-71. PubMed ID: 16091065
[TBL] [Abstract][Full Text] [Related]
39. Use of 5α-reductase inhibitors for benign prostate hypertrophy and risk of high grade prostate cancer: a French population-based study.
Scailteux LM; Rioux-Leclercq N; Vincendeau S; Balusson F; Nowak E; Oger E;
BJU Int; 2019 Feb; 123(2):293-299. PubMed ID: 30025199
[TBL] [Abstract][Full Text] [Related]
40. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study.
Lindblad M; Rodríguez LA; Lagergren J
Cancer Causes Control; 2005 Apr; 16(3):285-94. PubMed ID: 15947880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
